Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05663359

Study on Treatment of Varicose Veins by Endovenous Laser (1940 nm vs 1470 nm)

Randomized Comparative Study With Two Wavelengths 1470 nm and 1940 nm for the Treatment of Varicose Veins of the Lower Limbs by Endovenous Laser.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
280 (estimated)
Sponsor
Clinique Pasteur · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to compare efficacy of two wavelength for EndoVenous Laser Ablation (EVLA) in treatment of varicose veins of the lower limbs. The main questions it aims to answers are : 1. Is the increase of wavelength form 1470 nm to 1940 nm affect the efficacy of varicose veins treatment ? 2. Is the increase of wavelength reduce complication or pain ? Participants are patients with varicose veins of lower limbs and candidate for endovenous laser ablation. After laser ablation patients will be followed during 5 years for clinical evaluation, recording potential treatment complications and quality of life evaluation. Researchers will compare strategy 1(EVLA with an endovenous laser at 1940 nm) vs strategy 2 (EVLA with an endovenous laser at 1470 nm) in varicose veins treatment to see if efficacy of treatment is not reduce, and to see if complications of EVLA treatment can be reduced.

Conditions

Interventions

TypeNameDescription
PROCEDUREEVLA 1940 nmTreatment of varicose veins by endothermic ablation with an endovenous laser at 1940 nm
PROCEDUREEVLA 1470 nmTreatment of varicose veins by endothermic ablation with an endovenous laser at 1470 nm

Timeline

Start date
2023-02-24
Primary completion
2032-02-01
Completion
2032-02-01
First posted
2022-12-23
Last updated
2026-03-06

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05663359. Inclusion in this directory is not an endorsement.